Top Suppliers:I want be here

150727-06-3

150727-06-3 structure
150727-06-3 structure

Name 4-Tert-Butyl-N-(6-Chloro-5-(2-Methoxyphenoxy)-2,2-Bipyrimidin-4-yl)Benzenesulfonamide
Synonyms Bosentan Impurity 10(Bosentan Related Compound A)
4-tert-Butyl-N-[6-chloro-5-(2-methoxyphenoxy)-2-(2
Benzenesulfonamide, N-[6-chloro-5-(2-methoxyphenoxy)[2,2'-bi
Benzenesulfonamide, N-[6-chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)- (bosentan intermediate)
Benzenesulfonamide, N-[6-chloro-5-(2-methoxyphenoxy)[2,2-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)Q: What is Benzenesulfonamide, N-[6-chloro-5-(2-methoxyphenoxy)[2,2-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl) Q: What is the CAS Number of Benzenesulfonamide, N-[6-chloro-5-(2-methoxyphenoxy)[2,2-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl) Q: What is the storage condition of Benzenesulfonamide, N-[6-chloro-5-(2-methoxyphenoxy)[2,2-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl) Q: What e the applications of Benzenesulfonamide, N-[6-chloro-5-(2-methoxyphenoxy)[2,2-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)
Bosentan Related Compound 3
Bosentan Related CoMpound A
N-[6-Chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-tert-butylbenzenesulfonamide
N-[6-Chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)-(9CI)-benzenesulfonamide
4-tert-Butyl-N-[6-chloro-5-(2-methoxy-phenoxy) -[2,2']bipyrimidinyl-4-yl]-benzenesulfonamide
BenzenesulfonaMide(II)
bosentan intermediate(II)
Bosentan RC A
4-tert-Butyl-N-[6-chloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl]benzenesulfonamide
4-tert-butyl-N-[6-chloro-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide
4-tert-Butyl-N- (6-chloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide
Benzenesulfonamide, N-[6-Chloro-5-(2-Methoxyphenoxy)[2,2'-Bi-Pyrimidin]-4-Yl]-4-(1,1-Dimethylethyl)-(9ci)
4-(1,1-dimethylethyl)-N-[6-chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-benzenesulfonamide
N-[6-chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)
N-{6-chloro-5-(2-methoxy phenoxy)[2,2'-bipyrimidin]-4-yl}-4-(1,1-dimethylethyl)benzensulfonamide
N-[6-chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)-B
N-[6-Chloro-5-(2-methoxphenoxy)(2,2-bipyrimidine)-yl]-(1,1-dimethylethyl)-benzenesulfonamide
Bosentan Impurity-A
4-tert-Butyl-N-[6-chlor-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl]benzolsulfonamid
N-[6-CHLORO-5-(2-METHOXYPHENOXY) [2,2-BIPRIMIDIN]-4-(1,1-DIMETHYLETHYL) BENZENESULFONAMIDE
Bosentan Intermediate 2
N-[6-Chloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl]-4-(2-methyl-2-propanyl)benzenesulfonamide
Bosentan Related Compound A: 4-(tert-Butyl)-N-[6-chloro-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl]benzenesulfonamide
N-[6-Chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)-Benzenesulfonamide
Bosentan Related Compound A (4-(tert-butyl)-N-[6-chloro-5-(2-methoxyphenoxy)-(2,2''-bipyrimidin)-4-y
n-[6-chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)benzenesulfonamide
4-tert-Butyl-N-[6-chloro-5-(2-methoxy-phenoxy)-2-(pyrimidin-2-yl)-pyrimidin-4-yl]benzenesulfonamide
n-[6-chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimeth
Bosentan Related Compound A (15 mg) (4-(tert-butyl)-N-[6-chloro-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl] benzenesulfonamide)
4-TERT-BUTYL-N-(6-CHLORO-5- (2-METHOXYPHENOXY)-2,2'- BIPYRIMIDIN-4-YL)BENZENE
4-tert-Butyl-N-[6-chloro-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide
N-[6-CHLORO-5-(2-METHOXYPHENOXY)-(2,2-BIPYRIMIDINE)-YL]-(1,1-DIMETHYLETHYL)-BENZENESULFONAMIDE
Benzenesulfonamide, N-[6-chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)
N - [6-chloro-5- (2-methoxyphenyloxy) [2,2 '- pyrimidine] -4-yl] -4-tert butylbenzenesulfonamide
Density 1.3±0.1 g/cm3
Boiling Point 676.7±65.0 °C at 760 mmHg
Melting Point 212-214ºC
Molecular Formula C25H24ClN5O4S
Molecular Weight 526.007
Flash Point 363.1±34.3 °C
Exact Mass 525.123779
PSA 124.57000
LogP 3.55
Vapour Pressure 0.0±2.1 mmHg at 25°C
Index of Refraction 1.614
RIDADR NONH for all modes of transport

~99%

150727-06-3 structure

150727-06-3

Literature: INSTYTUT FARMACEUTYCZNY; SIDORYK, Katarzyna; ŁUNIEWSKI, Wojciech; PUCHALSKA, Maria; ŁASZCZ, Marta; MARUSZAK, Wioleta; KOŚCIUCH, Marta Patent: WO2014/104904 A1, 2014 ; Location in patent: Page/Page column 13; 14 ;

~%

150727-06-3 structure

150727-06-3

Literature: WO2013/186706 A1, ; Page/Page column 8 ;

~%

150727-06-3 structure

150727-06-3

Literature: WO2011/24056 A2, ;

~%

150727-06-3 structure

150727-06-3

Literature: WO2011/24056 A2, ;

~%

150727-06-3 structure

150727-06-3

Literature: WO2011/24056 A2, ;

~%

150727-06-3 structure

150727-06-3

Literature: WO2011/24056 A2, ;

~%

150727-06-3 structure

150727-06-3

Literature: WO2013/57545 A1, ;

~%

150727-06-3 structure

150727-06-3

Literature: WO2013/57545 A1, ;
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.